Identification of the RORα Transcriptional Network Contributes to the Search for Therapeutic Targets in

Hiroshi Matsuoka1, Akihiro Michihara1

  • 1Laboratory of Genomic Function and Pathophysiology, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.

Insights

Retinoic acid receptor-related orphan receptor α (RORα) plays a key role in metabolism and development. Targeting RORα offers potential therapeutic strategies for diseases like atherosclerosis and diabetes.

Area of Science:

  • Molecular biology
  • Endocrinology
  • Genetics

Background:

  • Retinoic acid receptor-related orphan receptor α (RORα) regulates critical physiological processes like metabolism and circadian rhythms.
  • RORα deficiency in mice leads to severe atherosclerosis, characterized by low high-density lipoprotein, elevated inflammatory cytokines, and tissue damage.

Purpose of the Study:

  • To review the current literature on RORα structure and function.
  • To discuss RORα's genetic variations and its therapeutic potential in atherosclerosis.

Main Methods:

  • Literature review of studies on RORα.
  • Analysis of RORα's role in physiological processes and disease models.
  • Examination of endogenous and synthetic RORα ligands.

Main Results:

  • RORα influences development, metabolism, and circadian rhythm.
  • RORα deficiency is linked to atherosclerosis, hypoalphalipoproteinemia, and inflammation.
  • Characterization of RORα ligands enables synthetic ligand development.

Conclusions:

  • RORα is a crucial regulator of lipid metabolism and inflammation.
  • Targeting RORα presents a promising therapeutic avenue for atherosclerosis, diabetes, and dyslipidemia.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
174
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
86
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K